Showing results (21-30 of 131) with videos related to
Sort By:
Pageof 14
Physical Review Letters|February 2, 2013
Electromagnetic vortex fields, spin, and spin-orbit interactions in electron vorticesS M Lloyd, M Babiker, J Yuan, et al.Expert Opinion on Investigational Drugs|July 27, 2017
Therapeutic potential of investigational CHK-1 inhibitors for the treatment of solid tumorsHani M Babiker, Ali McBride, Laurence S Cooke, et al.Anti-Cancer Drugs|February 3, 2021
Exceptional response to cyclophosphamide and dexamethasone in a patient with metastatic castrate-resistant prostate cancer and RB1 mutationBriana Dohogne, Hina Arif-Tiwari, Erika Bracamonte, et al.Saudi Medical Journal|January 3, 2017
Glycogenic hepatopathy, an underdiagnosed cause of relapsing hepatitis in uncontrolled type 1 diabetes mellitusAhmed A Al Sarkhy, Zafar A Zaidi, Amir M BabikerExpert Opinion on Investigational Drugs|April 4, 2018
Ublituximab for the treatment of CD20 positive B-cell malignanciesHani M Babiker, Ashley E Glode, Laurence S Cooke, et al.Case Reports in Hematology|April 24, 2019
A Rare Cause of Thrombotic Thrombocytopenia Purpura- (TTP-) Like Syndrome, Vitamin B12 Deficiency: Interpretation of Significant Pathological FindingsMorgan Bailey, Travis Maestas, Robert Betancourt, et al.Oncolytic Virotherapy|February 23, 2017
Oncolytic virotherapy including Rigvir and standard therapies in malignant melanomaHani M Babiker, Irbaz Bin Riaz, Muhammad Husnain, et al.Expert Opinion on Drug Safety|June 26, 2023
A drug safety evaluation of pemigatinib for advanced cholangiocarcinomaPedro Luiz Serrano Uson, Jeremiah Bearss, Hani M Babiker, et al.Oncolytic Virotherapy|January 19, 2019
Erratum: Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]Hani M. Babiker, Irbaz Bin Riaz, Muhammad Husnain, et al.Plant Disease|February 13, 2019
Optimum Timing of Preplant Applications of Glyphosate to Manage Rhizoctonia Root Rot in BarleyE M Babiker, S H Hulbert, K L Schroeder, et al.Pageof 14